Related Experiment Video
Updated: Jul 30, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia
Flávia Melo Cunha de Pinho Pessoa1, Caio Bezerra Machado1, Igor Valentim Barreto1
1Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
Acute myeloid leukemia (AML) arises from genetic and molecular changes in blood stem cells. Understanding these molecular and immunophenotypic alterations is key for AML diagnosis and targeted therapies.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Acute myeloid leukemia (AML) is a prevalent adult hematologic malignancy.
- Genetic mutations and chromosomal translocations drive leukemogenesis.
- Aberrant proteins resulting from these alterations are therapeutic targets.
Purpose of the Study:
- To investigate the relationship between molecular aberrations and immunophenotypic alterations in AML.
- To identify potential diagnostic and prognostic markers.
- To explore new therapeutic targets in AML.
Main Methods:
- Immunophenotyping to characterize cell surface antigens.
- Analysis of molecular aberrations including genetic mutations and cytogenetic abnormalities.
- Correlation of molecular and immunophenotypic data.
Main Results:
- Established correlations between specific molecular aberrations and immunophenotypic profiles in AML.
- Identified distinct immunophenotypic patterns associated with different cytogenetic abnormalities.
- Highlighted the role of immunophenotyping in refining AML classification.
Conclusions:
- Molecular and immunophenotypic analyses are crucial for understanding AML.
- These analyses can improve diagnostic accuracy and prognostic assessment.
- Findings support the development of targeted therapies based on specific AML subtypes.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018